Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar;9(2):150-5.
doi: 10.1097/COH.0000000000000035.

Drug use as a driver of HIV risks: re-emerging and emerging issues

Nabila El-Bassel  1 , Stacey A Shaw, Anindita Dasgupta, Steffanie A Strathdee
Affiliations
Review

Drug use as a driver of HIV risks: re-emerging and emerging issues

Nabila El-Bassel et al. Curr Opin HIV AIDS. 2014 Mar.

Abstract

Purpose of review: We reviewed the studies published in 2012-2013 that focused on re-emerging and emerging injection and noninjection drug use trends driving HIV risk behaviors and transmission in some parts of the world.

Recent findings: Although HIV incidence has declined in many countries, HIV epidemics remain at troubling levels among key drug-using populations, including females who inject drugs (FWIDs), FWIDs who trade sex, sex partners of people who inject drugs, young people who inject drugs, and people who use noninjection drugs in a number of low-income and middle-income countries such as in Central Asia, Eastern Europe, Southeast Asia, and parts of Africa.

Summary: HIV epidemics occur within the contexts of global economic and political forces, including poverty, human rights violations, discrimination, drug policies, trafficking, and other multilevel risk environments. Trends of injection and noninjection drug use and risk environments driving HIV epidemics in Central Asia, Eastern Europe, Southeast Asia, and parts of Africa call for political will to improve HIV and substance use service delivery, access to combination HIV prevention, and harm reduction programs.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest.

References

    1. Switzerland: UNAIDS; UNAIDS Report on the Global AIDS Epidemic: 2012.
    1. Beyrer C, Abdool Karim Q. The changing epidemiology of HIV in 2013. Curr Opin HIV AIDS. 2013;8(4):306–310. - PubMed
    1. Switzerland: UNAIDS; 2012. World AIDS Day Report: 2012.
    1. Des Jarlais DC, Pinkerton S, Hagan H, Guardino V, Feelemyer J, Cooper H, et al. 30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs. Adv Prev Med. 2013;2013:346372. - PMC - PubMed

    1. Des Jarlais DC, Feelemyer JP, Modi SN, Arasteh K, Mathers BM, Degenhardt L, et al. Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data. PLoS One. 2012;7(3):e31227. • This article examines transition patterns between IDU and heterosexual HIV epidemics, providing an important perspective on how drug use influences heterosexual HIV epidemics.

Publication types

MeSH terms